Company: BUDZ
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001096906-25-000350
Chunk: 389

Company: WEED, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 3
Chunk 389
---
,000 from Nicole Breen. From July 2023 to September 30, 2023, the company
paid off Glenn Marten’s loan of $500,000 and Nicole Breen’s loan of $50,000. From July 2024 to September, 2024, the Company
received $10,000 from Glenn Marten. From September 2024 to December 31, 2024, the Company received $300,000 from Glenn Marten and the
company paid off Glenn Marten’s loan of $5,000.

On May 2, 2022, the Company acquired the Hempirical
Genetics, LLC from Jeffrey Miller, and then Jeffrey Miller became the executive officer of WEED, Inc. Based on the agreement, the Company
owed Jeffrey Miller $120,000 as of June 30, 2023.

On July 1, 2022, Patrick Brodnik signed executive
employee agreement with the Company, and become one of the related parties since that. On various dates during the third quarter 2022,
the Company received advance of $3,661 from Patrick Brodnik at no interest. From April 2024 to June 2024, the Company paid off the advance
of $3,661.

Services

Nicole M. Breen receives $1,500 a week in cash compensation for her services
rendered to the Company.

Glenn E. Martin receives $8,000 a month in cash compensation for his services
rendered to the Company.

Accrued Compensation

A total of $202,750 and $182,500 of officer compensation
was unpaid and outstanding at December 31, 2024 and December 31, 2023, respectively.

Note 4 – Fair Value of Financial Instruments

Under FASB ASC 820-10-5, fair value is defined as
the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants
at the measurement date (an exit price). The standard outlines a valuation framework and creates a fair value hierarchy in order to increase
the consistency and comparability of fair value measurements and the related disclosures. Under GAAP, certain assets and liabilities must
be measured at fair value, and FASB ASC 820-10-50 details the disclosures that are required for items measured at fair value.

The Company has certain financial instruments that
must be measured under the new fair value standard. The Company